The definitive guide to understanding, evaluating, and choosing a compounding pharmacy for GLP-1 medications like semaglutide and tirzepatide
Over time, GeneDx plans to expand into newborn screening, a potentially $10 billion marketthen eventually into adult screening to replace multi-gene panel and individual gene tests, a future market pegged at $16 billion, Katherine Stueland, GeneDxs president and CEO, told GEN Edge last month With tougher comps in 25 and a potential headwind to revenues emerging in HCT, it is harder to argue for multiple expansion from here, Peterson said
Not this balm
They combine Riboflavin (vitamin B2) and other premium ingredients to accelerate the metabolism of fat cells, leading to their decomposition
This advanced delivery platform turns an otherwise unstable ingredient into a highly robust system, opening up brand-new possibilities of utilizing liposomal glutathione for professional cosmetic formulations